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ABSTRACT
PREDICTING DNA METHYLATION STATE OF CPG DINUCLEOTIDE
USING GENOME TOPOLOGICAL FEATURES AND DEEP NETWORKS
by Yiheng Wang
May 2016
The hypo- or hyper-methylation of the human genome is one of the
epigenetic features of leukemia. However, experimental approaches have only
determined the methylation state of a small portion of the human genome. I
developed a deep learning based (stacked denoising autoencoders, or SdA)
software named “DeepMethyl” to predict the methylation state of DNA CpG
dinucleotides using features inferred from three-dimensional genome topology
(based on Hi-C) and DNA sequence patterns. I used the experimental data from
immortalized myelogenous leukemia (K562) and healthy lymphoblastoid
(GM12878) cell lines to train the learning models and assess prediction
performance. I have tested various SdA architectures with different configurations
of hidden layer(s) and amount of pre-training data and compared the
performance of deep networks relative to support vector machines (SVM). Using
the methylation states of sequentially neighboring regions as one of the learning
features, SdA achieved a blind test accuracy of 89.7% for GM12878 and 88.6%
for K562. When the methylation states of sequentially neighboring regions are
unknown, the accuracies are 84.82% for GM12878 and 72.01% for K562. I also
analyzed the contribution of genome topological features inferred from Hi-C.
DeepMethyl can be accessed at http://dna.cs.usm.edu/deepmethyl/.
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CHAPTER I
INTRODUCTION
DNA methylation represents the addition of a methyl group to the fifth
carbon of the cytosine or adenine1. DNA methylation occurs more frequently at
CpG sites, where a guanine nucleotide follows a cytosine nucleotide in the
sequence of the genome2,3. In some regions, the frequency of CpG sites is up to
10 times greater than the average. These regions are called CpG islands
(CGIs)4. CpG islands have a GC percentage greater than 50% with at least 200
base pairs long. Generally speaking, CpG sites outside the CGIs are mostly
methylated, whereas CpG sites within CGIs are mostly unmethylated5. This
difference indicates that CGIs usually have distinguished patterns of methylation,
which may be important in gene regulation or gene mutation 6,7.
DNA methylation has been found to have influences on the expression of
gene and functional regulation of proteins8,9. According to recent studies10-12,
DNA methylation can affect the onset and progress of various cancers and
complex diseases. There are more methylated promoters and suppressors found
in abnormal cell lines13. The aberrance of DNA methylation is one of the typical
features of cancers such as acute myeloid leukemia14. However, the mechanistic
link between aberrance of DNA methylation and leukemia is not well understood.
Recent studies investigated DNA methylation in various cancers such as breast
cancer15,16. The results indicate that abnormal DNA methylation usually occurs at
some specific genomic locations17,18.
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Recent advances in methylation sequencing technologies allow the
identification of genome-wide methylated sites in DNA19,20. One way of profiling
methylation patterns of DNA is via the use of bisulfite treatment of DNA followed
by next-generation sequencing, which is known as bisulfite sequencing21. The
current bisulfite sequencing methods include whole-genome bisulfite sequencing
(WGBS)22 and reduced representation bisulfite sequencing (RRBS)23. Comparing
to WGBS, RRBS reduces the amount of sequencing by using representative
fractions of the genome. Therefore, RRBS specifically profiles and analyzes the
methylation pattern for the regions with a high CpG content24.
Methods have been developed to predict the methylation states at CpG
sites, windows or segments of a genome25-28. Most of the current methods for
methylation prediction assume that the methylation states are binary classes,
that is, a CpG site or a window is either methylated or un-methylated
(methylation-resistant)29. However, some other methods classified the
methylation level to multiple classes30. Among these methods, predictions were
usually limited to specific regions such as CGIs28,31. Predictive features used by
these methods included DNA composition32, GC content28, sequence patterns33,
and methylation state of neighboring region30. Recent methods also used pseudo
nucleotide composition to predict the methylations sites of a genome32,34. The
DNA composition and methylation state of sequential neighbors are the two most
common features among these methods30,33.
One of the features that has not been used in predicting DNA methylation
is chromosome interaction. The Hi-C technique enables the investigation of both
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intra- and inter-chromosomal contacts in a genome35. The analysis of the
genome at 1-1000 kilo-base resolution captures the overall genome spatial
conformational arrangements. The 1 kilo-base resolution would further capture
the contacts between the genes within the genome36. The Hi-C experiments cut
the crosslink DNA with restriction enzyme and ligate them under extremely dilute
conditions that favor intermolecular ligation. The experiments then purify and
shear the ligated DNA segments to obtain paired-end reads. The paired-end Hi-C
reads are mapped to the reference genome. After mapping, the data are binned
and normalized into the Hi-C contacts library, which indicates that certain
positions are spatially close in the three-dimensional space.
Although many methods have been developed to predict the methylation
state of specific regions, the prediction of the methylation state of CpG sites in
the loci of long non-coding RNAs (lncRNA) has received little attention. LncRNA
are transcripts of non-coding genes ranging from 200 bases to 100 kilo-bases
(kb) 37, yet their potential activities in human diseases have not been significantly
unveiled. Recent studies on gene expression indicate that lncRNA may function
as the connector between DNA and specific chromatin remodeling activities 38,
and the expression level of lncRNA usually is lower than the ones of proteincoding genes39. Furthermore, lncRNA expression might be a main factor in
carcinogenesis40. The exact mechanism of how lncRNAs influence cancer is
unknown, but abnormal lncRNA expression may be a factor causing cancer by
affecting major genetic processes. I evaluated my methylation predictions on the
CpG sites in lncRNA loci.

4
In this study, I applied a deep learning algorithm, stacked denoising
autoencoders (SdA), to predict DNA methylation status of CpG sites. Different
from traditional learning algorithms, the training of SdA contains two stages: an
unsupervised pre-training stage using unlabeled training data and a supervised
fine-tuning stage using labeled data (data with known target values). I used
sequential features generated within a window of the genome and features
generated from the three-dimensional topology of a genome indicated by the HiC experiment41. I did extensive tests of my method through several benchmarks.
In the first benchmark (Benchmark 1), I included the methylation level of
sequential neighboring regions as features, whereas in the second benchmark
(Benchmark 2), I excluded this type of features to increase prediction difficulty. I
also benchmarked the influences of unlabeled data in deep learning and the
influences of the genome topological features on the prediction accuracy.
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CHAPTER II
RESULTS
Overview
I built SVM and SdA models to predict binary DNA methylation status of
CpG sites (methylated or unmethylated). I applied my predictive models on
lymphoblastic cell lines (GM12878) and chronic myelogenous leukemia cell lines
(K562) to compare the performance of predictions on the healthy and cancer cell
lines. Two types of windows were defined to generate features from sequentially
and topologically neighboring regions of the genome (details see Methods). To
better understand the factors influencing the performance of SdA, I applied
different amounts of unlabeled pre-training samples, hidden layers, numbers of
denoising autoencoders in each layer, and pre-training and training epochs. I
also tested the performance of predicting methylation states of the CpG sites in
lncRNAs loci.
In Benchmark 1, I measured the performance of my predictors using the
metrics accuracy (Acc), specificity (Sp), sensitivity (Se), Matthews’s correlation
coefficient (MCC), and Receiver Operating Characteristic (ROC) curve using
leave-one-out cross-validation. For the blind test data, only test accuracy was
applied to evaluate the performance of SdA and SVM models. Different window-A
sizes of each target CpG site, from 500 to 1000 nt, were tested. The definition of
window-A can be found in the Methods section.
Moreover, I conducted Benchmark 2 by eliminating the features containing
the methylation state of sequential neighboring regions but only using features of
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(1) the methylation level of three-dimensional (3D) neighboring regions and (2)
sequential composition patterns of the DNA sequence. In order to find the impact
of the Hi-C based (3D genome topology) features, I tested the performance of
using features generated from randomly selected windows that do not have any
Hi-C contact to the target region. Different “Hi-C ranges” (from 10K to 50K) were
used to benchmark the impact of including different amounts of Hi-C window-B
(definition see Methods) features. In addition, I performed a blind test by
randomly combining the samples from chromosome 1 with the ones from
chromosome 21.
Chromosome-wide Analysis of Methylation Patterns and
Preparing Training and Testing data sets
The methylated and unmethylated samples were defined based on
parameters α and β (details see Methods). In order to balance my training
dataset, I examined the distribution of PercentMeth (explained in Methods)
values from RRBS experiments on chromosomes 1, 2 and 3 for GM12878 and
K562 (Figure 1). I found that the majority of CpG sites were either hypermethylated or hypo-methylated. Specifically, for GM12878 on chromosomes 1, 2
and 3, 67.73% of CpG sites have methylation level < 0.1 (hypo-methylated), and
14.40% of CpG sites have methylation level > 0.9 (hyper-methylated). Similarly,
for K562, 60.42% are hyper-methylated and 14.43% are hypo-methylated. Based
on this analysis, in order to balance the number of samples in methylated and
un-methylated classes for leave-one-out cross-validation and blind test, I set the
threshold β to be 0.01 making about half (46.25%) of the samples labeled as un-
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methylated. The threshold α was set accordingly to ensure the number of
methylated samples was equal to the one of un-methylated samples. In this way,
most of the samples were labeled into one of the binary classes, and no sample
was labeled twice.

Figure 1. Distribution of DNA methylation levels on CpG sites for chromosomes
1, 2 and 3 for GM12878 and K562
Optimizing Stacked Denoising Autoencoders (Benchmark 1)
The parameters of stacked denoising autoencoders include number of
hidden layers, number of hidden units in each layer, pre-training learning rate,
number of pre-training epochs, fine-tuning learning rate, and the maximum of
training epochs.
I optimized the parameters to obtain the best average performance on the
individual test samples in every round of leave-one-out cross-validation (Table 1).
In each round, one sample was chosen as the test sample, and the other
samples were equally split into one training set and one validation set. The
training set was also used for unsupervised pre-training of the SdAs. I found that
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after the SdA architecture reached 23-500-500-2 (23 input unites, two hidden
layers each with 500 hidden units, and two output nodes), the performance no
longer changed when increasing the number of hidden layers and number of
nodes in each layer. Therefore, the number of hidden layers was set to two, and
the number of hidden units in each layer was set to 500 for the leave-one-out
cross-validation and blind test. The setup of other parameters of SdA can be
found in the Methods section.
Table 1
Performance of SdA for GM12878 on chromosome 21 under different numbers of
hidden layers and different numbers of hidden units using leave-one-out crossvalidation.
Number of

200

200-200

500

500-500

hidden units

500-500500

and hidden
layers
Accuracy

0.889

0.891

0.896

0.935

0.935

Leave-one-out Cross-validations for Support Vector Machine and
Stacked Denoising Autoencoders (Benchmark 1)
In order to compare the performance of SVM, leave-one-out crossvalidation was conducted on chromosomes 1 and 21 for GM12878 and K562
with different window-A sizes (Figure 2). The output of the SVM classifier is a
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continuous number. Thus, I defined a cutoff µ to classify the output to discrete
classes (for details see Methods).

Figure 2. Leave-one-out cross-validation performance of SVM with different
window sizes, chromosomes, and cell lines: (A) prediction accuracy, (B)
specificity, (C) sensitivity, and (D) Matthews’s correlation coefficient.
By the comparison of accuracies (Figure 2A) and Matthew's correlation
coefficient (Figure 2D) of the two cell lines on chromosome 21 (black and green
line) and chromosome 1 (red and blue line), I found that the performance for
GM12878 is better overall than the performance for K562 on both chromosomes
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1 and 21 on SVM model. One of the reasons may be that the number of samples
for GM12878 is higher than K562 (Table 2), resulting from the different Hi-C
coverages in the two cell lines. The average number of Hi-C reads for each
nucleotide on GM12878 (chromosome 1 with 1.415 and chromosome 21 with
0.822) is higher than K562 (chromosome 1 with 0.371 and chromosome 21 with
0.206). In Benchmark 1, I included all the window-Bs that have at least one Hi-C
contact with window-A. A higher Hi-C coverage results in more samples having at
least one Hi-C contact and a higher number of window-Bs on average for each
target CpG site.
Table 2
Number of samples used in leave-one-out cross-validation on chromosomes 1
and 21 for cell lines GM12878 and K562 with window size 600nt.
Cell Line

Chromosome

Number of Samples

GM12878

21

296

K562

21

230

GM12878

1

2616

K562

1

1988

For both K562 and GM12878, SVM achieves better performance on
chromosome 21 than on chromosome 1 with most window sizes (Figure 2A, D).
However, the average specificity of prediction for K562 chromosome 1 does not
have a significant difference with prediction on chromosome 21 (Figure 2B).
Together with the lower sensitivity on chromosome 1 (Figure 2C), it indicates that
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the worse performance on chromosome 1 may be due to the worse performance
on predicting true positive (methylated) samples.
The ROC curves were generated for chromosome 21. I calculated the
values in the ROC curves by varying the cutoff µ from -2 to 2 (Figure 3). There is
not a common window size to obtain the best performance for all cell lines.
Figure 3 suggests that 600 nt is the best window size for GM12878 chromosome
21, which achieves an accuracy of 94.3%, Matthews’s correlation coefficient of
0.886, specificity of 0.919, and sensitivity of 0.966 (based on Figure 2). For K562,
800 nt is the best window size, which achieves an accuracy of 87.6%,
Matthews’s correlation coefficient of 0.753, specificity of 0.848, and sensitivity of
0.904. Table 3 summarizes the best performance that SVM achieves and the
corresponding window sizes.
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Table 3
The best performance achieved from leave-one-out cross-validation using SVM
on chromosomes 1 and 21 for cell lines GM12878 and K562. The threshold α
was used to ensure equal number of samples in methylated class and unmethylated class.
Cell Line

Chromosome

α

Window

Acc

Sp

Se

MCC

Size
GM12878

CHR1

0.55

500

0.900

0.894

0.905

0.800

GM12878

CHR21

0.99

600

0.942

0.918

0.966

0.886

K562

CHR1

0.07

600

0.823

0.863

0.784

0.649

K562

CHR21

0.43

800

0.876

0.848

0.904

0.753

Figure 3. ROC curves of leave-one-out cross-validation using SVM with different
window sizes for (A) GM12878 and (B) K562.
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To compare the performance between SdA and SVM, I conducted leaveone-out cross-validations for SdA on chromosomes 1 and 21 with window size
600nt (Table 4). On chromosome 21, SdA obtained a worse performance for
GM12878 with an accuracy of 0.935 compared to SVM’s accuracy 0.943.
However, on chromosome 1, the SdA model achieved a better performance with
an accuracy of 0.885, which is higher than SVM’s 0.839. Table 4 shows that the
number of samples in chromosome 1 (2,616) is about six times higher than the
ones for chromosome 21 (296), which may be one of the reasons for the
performance difference. This indicates that the SdA algorithm may need more
training samples to achieve better performance, whereas the SVM algorithm can
achieve a decent performance with a much smaller size of training data.
Table 4
Performance of leave-one-out cross-validation using SVM and SdA on
chromosomes 1 and 21 for cell line GM12878 on the window size 600nt.
Classifier

Cell Line

Chromosome

Acc

Number of
Samples

SdA

GM12878

CHR21

0.934

296

SVM

GM12878

CHR21

0.942

296

SdA

GM12878

CHR1

0.885

2616

SVM

GM12878

CHR1

0.839

2616
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Evaluating SVM and Stacked Denoising Autoencoders on
Blind Test Data Sets (Benchmark 1)
I further evaluated the performance of SVM and SdA using two blind test
data sets. The predictive models were trained using CpG sites on chromosomes
1, 2, and 3 with different window sizes for both healthy (GM12878) and cancer
(K562) cell lines. I used CpG sites on chromosomes 1, 2, and 3 as the training
set because chromosomes 1, 2, and 3 are the largest three chromosomes in
humans. The numbers of training samples associated with various window sizes
are shown in Figure 4. All features for the SVM and SdA classifiers were
generated from the same dataset. The CpG sites on chromosomes 21 and X
were selected as two independent test sets, considering that chromosome 21 is
a smaller chromosome and chromosome X can be inactivated by the lncRNAs
called Xist for female42. It would be interesting to study the methylation pattern in
X chromosome and compare it with chromosome 21.
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Figure 4. Number of training samples generated from chromosomes 1, 2 and 3.
Comparing to chromosome X, predictions on chromosome 21 for
GM12878 achieved a better performance on most window sizes (Figures 5 and
6). The difference may be due to the chromosome-specific methylation patterns. I
explored the distribution of the methylation level on chromosomes 21 and X
(Figures 7 and 8), which suggests that for both GM12878 and K562, methylation
distributions on chromosome 21 share similar patterns with the distribution on
chromosomes 1, 2, and 3 (Figure 1), which were used as the training data. For
example, on chromosome 21, 51.98% of the CpG sites have a methylation level
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< 0.1, and 15.44% of the CpG sites have methylation level >0.9 (Figure 7), which
is similar to 67.73% and 14.40% in chromosomes 1, 2, and 3 (Figure 1),
respectively. However, for GM12878 on chromosome X, CpG sites with
methylation level < 0.1 take a much lower proportion, that is, 33.24% (Figure 8),
which indicates that the methylation distribution in chromosome X is significantly
different from the distribution in chromosomes 1, 2, 3 (training data set), and 21
(the other test data set).

Figure 5. (A) Accuracy of blind test on chromosome 21 using SdA and SVM. (B)
Number of samples in the test dataset with different window sizes in
chromosome 21.
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Figure 6. (A) Accuracy of blind test on chromosome X using SdA and SVM. (B)
Number of samples in the test dataset with different window sizes in
chromosome X.

Figure 7. DNA methylation level distribution on chromosome 21 for GM12878
and K562
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Figure 8. DNA methylation level distribution on chromosome X for GM12878 and
K562.
Predicting Methylation State of lncRNA loci (Benchmark 1)
I investigated DNA methylation prediction for CpGs sites located within
lncRNAs genes. I used the same training data set, which is the combination of
CpG sites on chromosomes 1, 2, 3, and the test data set that contains the CpG
sites within lncRNAs genes on chromosomes 21 and X.
Benchmarking on chromosome 21 lncRNA loci: for both GM12878 and
K562 on chromosome 21, predictions for CpG sites within lncRNAs (Figure 9)
achieved better performance than the ones without region-specific limitation (that
is, both CpG sites within lncRNA genes and outsides lncRNA genes) (Figure 5).
Specifically, for K562, SdA reached the best accuracy of 0.977, while the best
accuracy is 0.886 for predictions on all CpG sites. This improvement in accuracy
may be because the methylation distribution patterns of chromosome 21
lncRNAs are more similar to the training dataset (chromosomes 1, 2 and 3) as
compared to the ones of all CpG sites. Thus, I explored the methylation patterns
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of CpG sites within lncRNA on chromosome 21 (Figure 10). I found that 60.42%
of the CpG sites within lncRNAs had a methylation level < 0.1 (Figure 10), which
is closer to the training dataset’s 67.73% (Figure 1) than 51.98% in CpG sites
without region-specific limitation (Figure 7).

Figure 9. (A) Performance of SdA for the prediction of methylation for lncRNAs
and CpG sites without region-specific limitation on chromosome 21. (B) Number
of samples in the test dataset on different window sizes in chromosome 21.
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Figure 10. DNA methylation level distribution of CpG sites within lncRNA on
chromosome 21 for GM12878 and K562.
Benchmarking on chromosome X lncRNA loci: furthermore, I found that
the performance for lncRNAs genes of GM12878 on chromosome X is worse
than the one on chromosome 21 (Figures 11 and 9). The difference of
performance for GM12878 on chromosome 21 and X may result from the
different characteristics of methylation for chromosomes 21 and X. Therefore, I
explored the distributions of the methylation levels of lncRNAs for chromosomes
21 and X (Figures 10 and 12). It can be found that for GM12878, the methylation
distribution of chromosome 21 lncRNAs shares similar patterns with the
methylation levels of all CpG sites (not only lncRNAs) in chromosomes 1, 2, and
3, which were used as the training data. Specifically, on chromosome 21, there
are 61.57% of lncRNA CpG sites have a methylation level < 0.1 (Figure 10),
which is similar to 67.73% on chromosomes 1, 2 and 3 (Figure 1). In contrast, on
chromosome X, only 31.65% of the lncRNA CpG sites have a methylation level <
0.1 (Figure 12), which indicates that the methylation distribution for lncRNA on
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chromosome X is quite different from the training data set comprised of
chromosomes 1, 2 and 3.

Figure 11. (A) Performance of SdA for the prediction of methylation for lncRNAs
and CpG sites without region-specific limitation on chromosome X. (B) Number of
samples in the test dataset on different window sizes in chromosome X.

Figure 12. DNA methylation level distribution of CpG sites within lncRNA on
chromosome X for GM12878 and K562.
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Moreover, since both K562 and GM12878 are samples from female, it is
possible that the X chromosome may be inactivated or in the process of
inactivation by an lncRNA called Xist42 that packs the three-dimensional structure
of X chromosome to disable the expressions of most X-chromosome genes. The
change of three-dimensional genome structure of X chromosome influences the
genome structural based features used in my methods and may also alter the
DNA methylation patterns in chromosome X. Moreover, another reason may be
that the test dataset of X chromosome is relatively small, compared to the one of
chromosome 21. Therefore, the influence of error becomes more significant
(Figure 11 B).
The Impact of Hi-C Based Genome Topological Features (Benchmark 2)
Benchmark 1 used the methylation level of sequential neighboring region
of a target CpG site. In Benchmark 2, I eliminated that feature in order to
benchmark the performance only based on the sequence composition of windowA and window-B (three-dimensional topological neighboring regions) in addition
to methylation levels in window-B. Compared to Benchmark 1, I added 74
PseTNC features for window-A and eight features for window B. All of these
newly added features indicate sequence composition. In Benchmark 2, I used
both up-sampling and down-sampling to balance training data. Details can be
found in the Methods section.
I also changed Hi-C based window-B to a randomly generated window-B
in order to observe the impact of Hi-C inferred topological neighbors. I only used
the randomly generated windows that do not have any Hi-C contact with the Hi-C
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ranges (the region surrounding a target CpG site that Hi-C neighbors were
collected from, see the Methods section for details). In this way, I eliminated
topological neighbors from the random windows. Different sizes of Hi-C ranges
were tested.
Table 5 shows the 5-fold cross-validation accuracy and MCC scores of
SVM on using both Hi-C based window-Bs and randomly selected windows. The
performance on Hi-C based and random windows is similar in this case with
random windows performing slightly worse. Tables 6-11 show the performance
of SdAs. I benchmarked one, two, and three hidden layer(s) and found that more
hidden layers result in significantly worse performance for randomly selected
windows.
Table 5
The SVM’s 5-fold cross-validation accuracy and MCC scores of using Hi-C based
topological neighboring window-Bs and random window-Bs on chromosome 1
with different Hi-C ranges.
Hi-C range

Acc (Hi-C based) Acc (random)

MCC (Hi-C based)

MCC random

10K

0.831

0.828

0.616

0.600

20K

0.833

0.810

0.618

0.584

30K

0.830

0.815

0.614

0.586

40K

0.837

0.832

0.623

0.606

50K

0.838

0.824

0.628

0.601
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Table 6
The 5-fold cross-validation accuracies of SdA on chromosome 1 with different HiC ranges.
Hi-C range

Hi-C_1L

Random_1L Hi-C_2L

Random_2L Hi-C_3L

Random_3L

10K

0.829

0.830

0.837

0.714

0.835

0.406

20K

0.839

0.839

0.828

0.668

0.829

0.376

30K

0.840

0.835

0.832

0.823

0.830

0.376

40K

0.828

0.835

0.831

0.831

0.828

0.565

50K

0.841

0.819

0.826

0.828

0.834

0.326

Note. The SdA model was trained with 10 pre-training epochs (unsupervised learning, learning rate 0.01) and 100 finetuning epochs (supervised learning, learning rate 0.01). The 1L, 2L and 3L are the number of hidden layers with
corruption levels of all layers set to 0.1. All the layers have 100 hidden nodes. Features based on genome topological
neighbors (window-Bs, indicated as “Hi-C” in the table) and features based on randomly selected regions (random
windows, indicated as “Random” in the table) were used to benchmark the impact of Hi-C based features.
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Table 7
The MCC scores for the same set up as in Table 6
Random
Hi-C range

Hi-C_1L

Random_1L

Hi-C_2L

Random_2L

Hi-C_3L

_3L

10K

0.611

0.600

0.628

0.549

0.627

0.040

20K

0.626

0.624

0.613

0.372

0.614

0.032

30K

0.627

0.619

0.620

0.604

0.614

0.018

40K

0.612

0.619

0.623

0.614

0.615

0.265

50K

0.635

0.602

0.617

0.615

0.623

0.050

Table 8
The accuracy of the same SdA architectures as in Table 6 with pre-training
epochs set to 10 and training epochs set to 10.

Random_2

Random

Hi-C range

Hi-C_1L

Random_1L

Hi-C_2L

L

Hi-C_3L

_3L

10K

0.794

0.795

0.777

0.6545

0.765

0.692

20K

0.787

0.776

0.768

0.7117

0.796

0.682

30K

0.793

0.773

0.768

0.766

0.798

0.712

40K

0.795

0.778

0.778

0.7668

0.777

0.699

50K

0.792

0.770

0.778

0.7807

0.789

0.777
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Table 9
The MCC of the same configuration as in Table 8.
Random_2
Hi-C range

Hi-C_1L

Random_1L

Hi-C_2L

Random
Hi-C_3L

L

_3L

10K

0.530

0.439

0.501

0.040

0.474

0.008

20K

0.525

0.495

0.488

0.056

0.324

0.036

30K

0.531

0.505

0.480

0.425

0.357

0.008

40K

0.528

0.501

0.501

0.426

0.000

0.066

50K

0.534

0.499

0.510

0.376

0.196

0.000

Table 10
The accuracy of the same SdA architectures as in Table 6 with pre-training
epochs set to 100 and training epochs set to 10.
Random_
Hi-C range

Hi-C_1L

Random_1L

Hi-C_2L

Random_2L

Hi-C_3L

3L

10K

0.773

0.690

0.763

0.639

0.765

0.642

20K

0.801

0.699

0.768

0.641

0.776

0.759

30K

0.791

0.67

0.764

0.715

0.771

0.662

40K

0.777

0.699

0.765

0.643

0.759

0.649

50K

0.795

0.739

0.795

0.634

0.763

0.625

27
Table 11
The MCC scores for the same configurations in Table 10.
Random
Hi-C range

Hi-C_1L

Random_1L

Hi-C_2L

Random_2L

Hi-C_3L

_3L

10K

0.484

0.003

0.493

-0.003

0.495

-0.04

20K

0.375

0.044

0.508

-0.001

0.519

0.011

30K

0.392

0.026

0.502

0.017

0.507

0.015

40K

0.103

0.091

0.503

0.009

0.484

0.008

50K

0.276

0.027

0.499

-0.003

0.494

-0.005

In order to benchmark the influence of unsupervised pre-training of SdAs,
I conducted three independent 5-fold cross-validations, in which the epochs of
unsupervised pre-training and supervised training were set to (10, 100) (Tables 6
and 7), (10, 10) (Tables 8 and 9), and (100, 10) (Tables 10 and 11) while unifying
all the other factors, including pre-training, training, validation, and testing data
and other SdA parameters. The results show that larger epochs for unsupervised
pre-training and smaller epochs of supervised training may decrease
performance and make the SdAs perform significantly worse for random
windows. The epochs of unsupervised pre-training and supervised training of
(10, 100) generated the best performance.
Blind Test on Chromosome 21 and LncRNA Loci (Benchmark 2)
I tested the performance on randomly combined samples from
chromosomes 1 and 21 (details of data generation see Methods). For SdAs, the
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epochs of unsupervised pre-training and supervised training was set to (10, 100),
and the other parameters remained the same as the 5-fold cross-validation that
generated the best results. Similar findings as in the 5-fold cross-validation were
observed. That is, a higher number of hidden layers makes the SdA perform
significantly worse on the random windows in GM12878 (Table 12). For K562,
the SdA model achieved an accuracy of 72.01%. I also benchmarked the
performance on the CpG sites without genome topological features (no Hi-C
signals); and in this case, the accuracies of GM12878 and K562 are 84.25% and
69.95%, respectively.
Table 12
The blind test accuracy and MCC scores for SdA and SVM on randomly
combined training and testing samples from chromosomes 1 and 21 with Hi-C
range 10K.
Classifier Features

SdA architecture

Acc

MCC

SdA

Hi-C based window-B

109-100-2

0.871

0.666

SdA

Random window-B

109-100-2

0.810

0.612

SdA

Hi-C based window-B

109-100-100-2

0.867

0.659

SdA

Random window-B

109-100-100-2

0.631

0.058

SVM

Hi-C based window-B

NA

0.860

0.685

SVM

Random window-B

NA

0.858

0.725

Note. The ration of fine-tuning, validation, and testing samples for SdA is 3:1:1. With two hidden layers, the MCC score of
SdA is 0.058. I found that the predictions are highly biased to negative samples. This causes the false negative to be a
value close to 1. Therefore, it has a very low MCC score.
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Using the optimized SdA configuration and SVM model found in the 5-fold
cross-validations, I tested their performance on GM12878 chromosome 21
lncRNA loci (Table 13). Two hidden layers of SdA generated the best testing
accuracy that is similar to SVM. In terms of MCC score, two-hidden-layer SdA
(0.6427) performed slightly better than SVM (0.6385).
Table 13
Performance of SdA and SVM for predicting methylation level of CpG sites within
lncRNA regions.
Classifier

SdA architecture

Acc

MCC

Number of test
samples

SdA

109-100-2

0.796

0.5678

2138 (551 positive,
1587 negative)

SdA

109-100-100-2

0.784

0.5617

2138

SdA

109-100-100-100-2 0.832

0.6427

2138

SVM

NA

0.6385

2138

0.837

Note. The SdA architecture and SVM model used were the one with the best test accuracy in 5-fold cross-validation on
chromosome 1 (Tables 6-11). The number of testing lncRNA samples are 2,138 (551 positive and 1587 negative).

Benchmarking the Parallel Algorithm for Generating
Features and Training SVMs
A parallel algorithm was used to reduce the execution time of the entire
feature generation process. The parallel algorithm was implemented using C++
and MPICH, and the performance tests were conducted on my own shared
memory server equipped with 48 CPUs with speed 1200 MHz and 126 gigabytes
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of memory. A test result is given in Table 14, which shows that my parallel
method dramatically saves computational time.
Table 14
Execution time (seconds) and corresponding Speedup (time of using one
process divided by the time using x processors, x = 2, 4, 6, and 16) on
chromosome 21 of K562.
Number of

P=1

P=2

P=4

P=8

P=16

703.05

370.69

201.41

99.97

56.58

1.89

3.49

7.03

12.43

Processes
Time
Chr21
Speedup -
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CHAPTER III
DISCUSSIONS
I developed SVM and SdA models to predict binary methylation state of
CpG sites on GM12878 and K562 on different chromosomes with different
window sizes. In the leave-one-out cross-validation for SVM classifier, the
accuracy reaches 0.943 on chromosome 21 of GM12878, while the accuracy
reaches 0.876 on chromosome 21 of K562. The distinction of performance
between GM12878 and K562 on the SVM model may result from the different
numbers of samples and Hi-C coverage. This indicates that the Hi-C reads
coverage plays an important role, as a higher Hi-C coverage can increase the
resolution of the three-dimensional genome structure and provide more
neighboring CpG sites as features for the machine learning models.
Furthermore, I evaluated the SdA classifier using a leave-one-out crossvalidation. For SdA classifier tested on 296 CpG sites of GM12878 chromosome
21, the accuracy reaches 0.935, which is slightly lower than SVM classifier’s
0.943. However, on chromosome 1 for GM12878, in which the total number of
leave-one-out samples reaches 6,516, the accuracy of SdA classifier reaches
0.885, which is obviously higher than SVM classifier’s 0.839. The difference of
performance between SVM and SdA may suggest that the SdA algorithm needs
more training samples to achieve better performance. Moreover, by comparing
the performance with features excluding methylation level of neighbors and GC
contents, I found that, especially for SdA, neighboring methylation levels and GC
content are influential to the prediction performance.
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Moreover, I evaluated the performance of SVM and SdA classifiers using
two blind test sets. My experiments used chromosomes 1, 2 and 3 as the training
set, and chromosomes 21 and X as two independent test data sets. SdA reaches
the best accuracy of 0.897 on chromosome 21 of GM12878 with window size
500nt. On chromosome 21, both SVM and SdA have a stable performance over
different window sizes for both K562 and GM12878. For chromosome X, SdA
achieved a best accuracy of 0.880 for GM12878 with window size 900 nt.
Overall, the accuracies of GM12878 on chromosome X are lower than the ones
on chromosome 21 for most window sizes. This may be because the distributions
on chromosome X are largely different from the distributions in the training
dataset of chromosomes 1, 2, and 3.
I investigated the performance of predicting the DNA methylation state for
CpG sites within lncRNA DNA locus. The best accuracy, 0.977, was obtained
when using SdA on chromosome 21 of K562 with window size 500nt. I further
found that the performance on chromosome X was overall worse than the
performance on chromosome 21. By analysis, I found that the methylation
distribution of lncRNA genes in chromosome X of GM12878 was largely different
from the distributions found in both chromosome 21 and the training
chromosomes 1, 2, and 3. This may result from the existence of an lncRNA
called Xist that packs and inactivates the chromosome X of female causing the
different methylation patterns. My data indicates methylation patterns of lncRNA
may be chromosome- and cell line-specific.
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In order to benchmark the influence of Hi-C based genome topological
features, I replaced Hi-C neighbors with randomly selected windows and then
benchmarked the performance. I found that using random windows significantly
decreased the performance of SdAs with two or more hidden layers. I also tested
it with different numbers of epochs for pre-training and fine-tuning and found that
a larger number of fine-tuning increases performance, whereas a larger number
of pre-training decreases the performance.
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CHAPTER IV
METHODS
Datasets
Human cell lines: the cell lines GM12878 and K562 were selected for my
study because of their accessibility and sufficient experimental data associated
with them. GM12878 is a B-lymphocyte cell line from a female, while K562 is an
immortalised cell line from a female patient with chronic myelogenous leukemia
(CML) (for description of these two cell lines see
http://www.genome.gov/26524238). Thus, investigating the methylation
prediction on these two cell lines may help me characterize the methylation
patterns of cancer and healthy cell lines.
DNA methylation data: DNA methylation state at each CpG dinucleotide is
measured by Reduced Representation Bisulfite Sequencing (RRBS) data. RRBS
methylation data for cell lines GM12878 and K562 were obtained from the
ENCODE project
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeHaibM
ethylRrbs/).
Genome topology: the Hi-C paired reads36 for GM12878 and K562 cell
lines were obtained from the public accessible NCBI GEO database
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM1181867) and NCBI
SRA database (accessible at
http://sra.dnanexus.com/experiments/SRX011614/runs), respectively. The pairedend Hi-C reads were mapped to the human reference genome (UCSC version
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hg19) using the read sequence alignment tool Maq43. The contact library
containing spatial contacts between pairs of genomic positions were generated
by parsing the Maq mapping outputs. Each contact between two positions on
genome implies that they are spatially proximate in three-dimensional structure.
Support Vector Machines (SVM)
There are four types of kernel functions in SVM-Light44: linear, polynomial,
radial basis function, and sigmoid. In Benchmark 1, I selected the polynomial
kernel function for my SVM classification model because this kernel function
achieves the best performance based on the 23 features using leave-one-out
cross-validation (data not shown). Based on the optimization of SVM model, the
parameter C (trade-off between training error and margin) was set to 5, and the
polynomial kernel function parameter d was set to 3. In Benchmark 2, the radical
basis function was selected as the kernel function based on the cross-validations
on 109 features. I used the default value of parameter C in SVM-light and set the
parameter gamma in radical basis function to 9 based on optimization.
Deep Learning - Stacked Denoising Autoencoder
The deep learning architecture applied to this research is Stacked
Denoising Autoencoder (SdA)45 implemented with Theano
(http://deeplearning.net/software/theano/). Theano is a Python-based library
enabled GPU-based high performance computing for deep networks. The SdA
algorithm composed of two phases of learning. The first phase is unsupervised
pre-training carried out by layers of denoising autoencoders, which learn a
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reconstruction Z from corrupted version of data X by minimizing the crossentropy of the reconstruction:
𝑑

𝐿𝐻 (𝑋, 𝑍) = − ∑𝑘=1[𝑋𝑘 𝑙𝑜𝑔 𝑍𝑘 + (1 − 𝑋𝑘 )𝑙𝑜𝑔(1 − 𝑍𝑘 )]

(1)

for all the training samples in a minibatch. The Z, which is the
reconstruction of the corrupted version of data X, was computed from
𝑍 = 𝑆(𝑊 ′ 𝑦 + 𝑏′)

(2)

where 𝑊 ′ is the reconstruction weighting matrix, 𝑏′ is the reconstruction
bias, and function 𝑆() is a sigmoid function:
1

𝑆(𝑡) =  1+𝑒 −𝑡

(3)

Also, Z, the reconstruction of the corrupted input X, can be considered as
the prediction of X because it tries to have the same shape of X given y, where
𝑦 = 𝑠(𝑊𝑥 + 𝑏)

(4)

in which 𝑠() is a sigmoid function, W is the weighting matrix, and b is the
bias. Formula 4 maps the corrupted input 𝑋𝜖[0, 1]𝑑 to a hidden
representation𝑦𝜖[0, 1]𝑑′ , which is reversely mapped by Formula (2) to build a
reconstruction of corrupted data X by minimizing Formula (1). The corrupted
input X is a sparse version of the original input X-orig. There are multiple ways to
generate X from X-orig, and I used a parameter called corruption level to set it.
The hidden units in a hidden layer were randomly selected to be disabled from
an input node based on the probability set by the corruption level parameter. This
corrupted version of autoencoders does not only learn the identifiers of the input
data but also learns the features that are more useful to the problem. Therefore,
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it is also named denoising autoencoders46. This corruption process was applied
in each layer of hidden units in stacked denoising autoencoders.
The learning process computes the cost based on Formula (1) for each
layer of stacked denoising autoencoders and updates the weights and biases by
gradient descent. The training process starts from the first layer directly
connecting to the input data, and continues layer by layer. The trained m layers
enable the computation of latent representation in layer m+1. In this way, all
stacked layers of denoising autoencoders were trained, and the outputs from
these layers of denoising autoencoders are the reconstruction of input X-orig or
the features selected from the original data. With that, the unsupervised pretuning part is finished.
A supervised fine-tuning is applied after the unsupervised pre-tuning. A
logistic regression model was added on top of the layers of denoising
autoencoders that calculates:
P(Y = i|x, W, b) = softmaxi (Wx + b) = 

𝑒 𝑊𝑖 𝑥+𝑏𝑖
𝑊 𝑥+𝑏𝑗
∑𝑗 𝑒 𝑗

.

(5)

This formula calculates the probability of an input vector x having the class
i of Y. W is the weighting matrix; b is the bias; and j can be all the possible
classes in Y. After calculating the probabilities for all possible classes in Y, an
input vector x is assigned or predicted to the class that gives highest probability
as:
𝑦𝑝𝑟𝑒𝑑 = 𝑎𝑟𝑔𝑚𝑎𝑥𝑖 𝑃(𝑌 = 𝑖|𝑥, 𝑊, 𝑏) .
A multilayer perceptron is constructed that shares the same number of
layers, number of neurons in each layer, weight, and bias as previously trained

(6)
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stacked denoising autoencoders. Label value Y was used to train the multilayer
perceptron by a backpropagation algorithm with logistic function as activation
function. In this way, the multilayer perceptron was trained, and the entire
learning architecture was fine-tuned. Therefore, the weights and bias in each
hidden layer of the deep network were updated again based on the class label y
of each training sample.
Based on my Benchmark 1 (see Results), the best configuration achieving
optimal performance contains two hidden layers each with 500 hidden units; the
pre-training learning rate and epochs were set as 0.01 and 100; the fine-tuning
learning rate was set as 0.1; and the maximum of training epochs was set as
1000. In Benchmark 2, the learning rates of pre-training and fine-tuning were set
to 0.01; corruption level was set to 0.1 for all hidden layers. Different epochs for
pre-training and fine-tuning were tested (see Results). The SdA algorithm was
implemented on a NVIDIA Quadro K5100 GPU with 1,536 CUDA parallel
processor cores.
Machine Learning Features
Overview: I defined two types of windows for each CpG site to generate
features. The first type of window, window-A, is a DNA sequence window with the
target CpG site as the center whose size varies from 500 to 1000nt. Window-A
was used to generate features from the sequence that are immediately adjacent
to the target CpG sites. The second type of window, window-B, is a sequence
window with point X in the center, whereas point X and a point in window-A (for
Benchmark 1) or “Hi-C range” (for Benchmark 2, definition see below) must be in
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contact indicated by a Hi-C paired ends read. The coordinates of CpG sites and
corresponding window sequences were determined based on human reference
genome hg19.
Features from window-A: there are four types of DNA nucleotides: adenine
(A), thymine (T), guanine (G), and cytosine (C). Both the ratio and order of these
four nucleotides indicate important features of the DNA sequence. Studies 27,33
have proved that the occurrence of certain DNA patterns may be related to the
methylation level. Hence, for Benchmark 1, the ratios of A, T, G, C and eight
specific fragments (sequential signatures, Table 15), which have been proven to
be useful features for methylation prediction25, were used as features for my
prediction. In some recent studies30, the methylation state of neighboring regions
was incorporated as one of the features. Hence, the “percentMeth” values from
RRBS experiments indicating averaged methylated percentage were gathered
and averaged in window-A, and then were included as a type of feature in
Benchmark 1.
Table 15
Features used for machine learning algorithms and their descriptions.
Feature name

Feature description

Used in
benchmark
:

Ra_A

Ratio of adenine in window-A

1, 2

Ra_B

Ratio of thymine in window-A

1, 2

Ra_C

Ratio of guanine in window-A

1, 2
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Ra_D

Ratio of cytosine in window-A

1, 2

Pa_AAWGGR

Pattern frequency of AAWGGR in

1, 2

window-A
Pa_TGRAAT

Pattern frequency of TGRAAT in

1, 2

window-A
Pa_AAT

Pattern frequency of AAT in window-A

1, 2

Pa_ATGVAA

Pattern frequency of ATGVAA in

1, 2

window-A
Pa_ACG

Pattern frequency of ACG in window-A

1, 2

Pa_GC

Pattern frequency of GC in window-A

1, 2

Pa_CG

Pattern frequency of CG in window-A

1, 2

Pa_TG

Pattern frequency of TG in window-A

1, 2

Pa_CCGC

Pattern frequency of CCGC in window-A

2

Pa_CCCC

Pattern frequency of CCCC in window-A

2

Pa_CGCC

Pattern frequency of CGCC in window-A

2

Pa_AAAG

Pattern frequency of AAAG in window-A

2

Pa_CTCC

Pattern frequency of CTCC in window-A

2

Ave_ meth

Average methylation level in window-A

1

PseTNC

74 pseudo tri-nucleotide composition

2

features (Detail see Methods)
Ave_meth_Hi_C

Average methylation level in window-Bs

1, 2

Ave_Ra_A_Hi_C

Average Ra_A in window-Bs

1, 2
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Ave_Ra_B_Hi_C

Average Ra_B in window-Bs

1, 2

Ave_Ra_C_Hi_C

Average Ra_C in window-Bs

1, 2

Ave_Ra_D_Hi_C

Average Ra_D in window-Bs

1, 2

Ave_Pa_AAWGGR_Hi

Average Pa_ AAWGGR in window-Bs

1, 2

Average Pa_ TGRAAT in window-Bs

1, 2

Ave_Pa_AAT_Hi_C

Average Pa_ AAT in window-Bs

1, 2

Ave_Pa_ATGVAA_Hi_

Average Pa_ ATGVAA in window-Bs

1, 2

Ave_Pa_ACG_Hi_C

Average Pa_ ACG in in window-Bs

1, 2

Ave_Pa_CCGC _Hi_C

Average Pa_CCGC in window-Bs

2

Ave_Pa_CCCC _Hi_C

Average Pa_CCCC in window-Bs

2

Ave_Pa_CGCC _Hi_C

Average Pa_CGCC in window-Bs

2

Ave_Pa_AAAG _Hi_C

Average Pa_AAAG in window-Bs

2

Ave_Pa_CTCC _Hi_C

Average Pa_CTCC in window-Bs

2

Ave_Pa_GC _Hi_C

Average Pa_GC in window-Bs

2

Ave_Pa_CG _Hi_C

Average Pa_CG in window-Bs

2

Ave_Pa_TG _Hi_C

Average Pa_TG in window-Bs

2

_C
Ave_Pa_TGRAAT_Hi_
C

C

Note. The feature names containing “Hi_C” were generated in window-B, that is, the topological neighbors indicated by
Hi-C experiments.
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For Benchmark 2, that is, the 5-fold cross-validation on chromosome 1
and blind test on random combination of chromosomes 1 and 21, I incorporated
more sequential features and eliminated the features indicating methylation level
in neighboring region. As introduced by some recent publications47-62, some
useful statistical features for biological systems have been developed and
presented. These features include pseudo amino acid composition (PseAAC)63,
pseudo k-tuple nucleotide composition (PseKNC) and pseudo trinucleotide
composition (PseTNC)64. I implemented 74 PseTNC features as DNA sequence
property features. The pseTNC (pseudo trinucleotide composition) is a statistical
feature, which incorporates the occurrence frequencies of all the pseudo
trinucleotide compositions. The features are defined as
D = [𝑑1 𝑑2 … 𝑑64 …𝑑64+λ

(7)

in which the first 64 features measure the local or short-range sequence pattern
and the next λ = 10 components measure the global effect. The 74 features were
generated by incorporating the frequency and multiple physical properties of
each pseudo trinucleotide composition. The detail of calculating these features
can be found in the reference64.
Features based on three-dimensional genome topology - Benchmark 1:
for each target CpG site, I gathered all the Hi-C contact pairs with one end falling
into the window-A region. Using the other Hi-C end as the center, a window-B
was defined with the same size of window-A. I only included the window-Bs that
are > 1000nt away from the target CpG sites ensuring they are sequentially a
long-distance away but proximate in three-dimensional space. In this way, I
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eliminated the methylation level of the sequentially neighboring region for a target
CpG site. Because multiple Hi-C pairs may have one end falling into the windowA region of each target CpG site, I usually gathered multiple window-Bs. The
number of available window-Bs is influenced by the size of window-A and the HiC reads coverage, which was calculated by: multiplying the length of Hi-C read
by the number of Hi-C reads and then dividing by the total length of the reference
genome. I benchmarked my performance with different sizes of window-A. For
each window-B, I generated the DNA sequence properties (Table 15) and
averaged methylation PercentMeth, and then averaged these values for multiple
window-Bs.
Benchmark 2: I eliminated the methylation level in window-A, but only kept
the methylation levels in window-B for every target CpG sites. In this way, the
prediction models no longer know the methylation level in the sequential
neighboring region of a target CpG site, increasing the prediction difficulty. In
order to observe how the number of Hi-C neighboring regions impact prediction
performance, a “Hi-C range” was defined with the target CpG site as the center
of it. The Hi-C pairs with one end fell into this “Hi-C range” and were collected;
and the other end was used as the center of window-B. Only the Hi-C contacts
whose two ends have a sequential distance longer than the “Hi-C range” were
included so that only long-range spatial neighbors were kept.
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Evaluation Methods
Evaluation criteria: the specificity (Sp), sensitivity (Se), accuracy (Acc),
and Matthews’s correlation coefficient (MCC) were used to evaluate prediction
performance. These parameters were calculated using the following equations65:
𝑁+

(8)
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Sn = 1 −  𝑁−+

Sp = 1 −  𝑁+−

𝑁 + +𝑁−

Acc = 1 −  𝑁−++𝑁+−
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+
)
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−
−
+
+
√(1 + 𝑁+ −+𝑁− )(1 + 𝑁− −−𝑁+ )
𝑁
𝑁

(10)

1−(

(11)

where 𝑁 + is the total number of the positive samples (methylated
samples), and 𝑁−+ is the number of the positive samples incorrectly predicted as
negative samples (un-methylated samples), 𝑁 − is the total number of the
negative samples, and 𝑁+− is the number of negative samples incorrectly
predicted as the positive samples.
Receiver Operating Characteristic (ROC) curves for leave-one-out crossvalidation were plotted with different values of threshold µ, which was used as
the cutoff for methylated and unmethylated classes based on the SVM output
real-number value.
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Leave-one-out Cross-validation (Benchmark 1)
The performance of SVM model and SdAs were evaluated by the leaveone-out cross-validation. For the prediction of methylation state of each CpG site,
the rest of the CpG sites were used as training samples. For SdA, the rest of the
samples were split so that 50% of the samples were used as fine-tuning set and
50% as validation set. The same fine-tuning samples were also used in the pretraining stage (unsupervised learning), in which the target values Y were not
used. The final evaluation of the prediction performance was obtained by
averaging the results from all round of cross-validation.
The methylation value for each CpG site was indicated by the value of
percentMeth from RRBS experiments. Methylation level of a CpG site is a
continuous value ranging from 0 (un-methylated) to 1 (methylated). Because I
tried to classify the methylation status of a CpG site into binary classes
(methylation state), that is, either methylated or un-methylated, I incorporated two
thresholds α and β to convert the continuous value of PercentMeth into binary
classes. Specifically, if the PercentMeth value of a CpG site is larger than α, the
CpG site is classified as methylated, and if the methylation level of a CpG site is
less than β, the CpG site is classified as un-methylated (methylation-resistant).
The threshold β was set first to 0.01, and then the threshold α was calculated
based on β to ensure these two binary classes would have equal numbers of
samples. Balancing the number of samples in each class avoids bias in training.
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Blind Test on Chromosomes 21 and X (Benchmark 1)
The chromosomes 1, 2, and 3 were used as training data sets because of
their relatively larger size, and chromosomes 21 and X were selected as two
independent blind testing data sets because of their smaller size and the possible
inactivation of female X chromosome.
Five-fold Cross-validation (Benchmark 2)
In Benchmark 2, I eliminated the feature “Ave_meth” (methylation level in
the neighboring region of target CpG sites) and added 74 PseTNC features
(Table 15). I collected all the CpG sites with “PercentMeth” value in the RRBS
experiment equal to 0 and assigned them as un-methylated samples; the CpG
sites with >= 0.9 were used as positive samples. In this way, I collected in total
559 positive samples and 1,959 negative samples. These samples were evenly
split into five folds. For the training of SVM, down-sampling (cut samples from the
majority class) was performed on the four training folds. The up-sampling
technique (randomly picking up the same number of samples for the minority
class) was performed for SdA in order to balance the positive and negative
samples in the training folds. The data in the testing fold was not balanced. For
SdAs, three folds were used as fine-tuning data (up-sampling balanced), one fold
as validation (up-sampling balanced), and one fold as test (not balanced).
Benchmark 2 was performed on chromosome 1 of the GM12878 cell line.
In order to benchmark the contribution of unsupervised pre-training of
SdAs, I randomly collected 2,330 samples in chromosome 1 with unknown target
value. For every round in the 5-fold cross-validation and blind test with
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chromosome 21, this data set was used as the pre-training sample for training
SdAs. This 5-fold cross-validation was performed with multiple “Hi-C range”
(definition see Machine Learning Features section).
Blind test with Chromosome 21 (Benchmark 2)
I collected 1,039 positive and 1,746 negative samples from chromosome
21 in the same way as from chromosome 1, and randomly combined them with
all the samples from chromosome 1 used in the 5-fold cross-validation. All of the
randomly combined data set was split into five folds. For SVM, four folds were
used to train the model and one for test. For SdAs, three folds were used as finetuning, one fold for validation, and one for testing. The same un-labeled data set
was used for unsupervised pre-training. No up-sampling or down-sampling was
performed on any of the folds. Only 10K “Hi-C range” was used in this blind test
stage
Test with randomly selected windows (Benchmark 2)
To benchmark the contributions of Hi-C related features, I replaced Hi-C
based window-Bs with same-size random windows, which do not have any Hi-C
contacts with the “Hi-C range” of a target CpG site. All the same features were
generated on the random window as for Hi-C window-B.
Parallelization of Feature Generation and SVM Classification
A parallel algorithm was designed to reduce the execution time of feature
generating and SVM-light classification. First, multiple processors simultaneously
read the Hi-C contact files using MPI (Message Passing Interface), and then a
parallel version of SVM-light was developed to make each processor perform
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learning and classification simultaneously. This parallel algorithm was designed
and tested on an early version of my methods that targeted on predicting
average methylation level of a segment of the genome instead of each CpG site.
However, the feature types and SVM classification are the same. Execution time
decreased with the increase of number of processors (see the Results section).
Statement for Experiments Involving Vertebrates and Human Subjects
This research was conducted with purely computational methods and did
not use any animals, human subjects, or tissue samples. This work did not
conduct any wet lab biological experiments that used vertebrates, human
subjects, or tissue samples. The data of all cell-lines were downloaded from the
public database ENCODE that has already been previously published.
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